(Q45381982)

English

Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan

scientific article published on 19 August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan (English)

1 reference

Europe PubMed Central

14 December 2017

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

John Jenn-Yenn Lu

1

1 reference

Europe PubMed Central

14 December 2017

Chi-Chia Cheng

2

1 reference

Europe PubMed Central

14 December 2017

Shieu-Ming Chou

3

1 reference

Europe PubMed Central

14 December 2017

Chang-Bor Hor

4

1 reference

Europe PubMed Central

14 December 2017

Yi-Chen Yang

5

1 reference

Europe PubMed Central

14 December 2017

Hsiang-Ling Wang

6

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

19 August 2009

1 reference

Europe PubMed Central

14 December 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

14 December 2017

27

1 reference

Europe PubMed Central

14 December 2017

47

1 reference

Europe PubMed Central

14 December 2017

6613-6618

1 reference

Europe PubMed Central

14 December 2017

Hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

The natural history of asymptomatic hepatitis B surface antigen carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Incidence of hepatitis B virus infections in preschool children in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Incidence of hepatitis among students at a university in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Legend of hepatitis B vaccination: the Taiwan experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Long-term protection against carriage of hepatitis B virus after infant vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Hepatitis B vaccine responsiveness in Connecticut public safety personnel

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Family study of non-responsiveness to hepatitis B vaccine confirms the importance of HLA class III C4A locus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Hepatitis B vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Long-term protection of hepatitis B vaccine 18 years after vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Impact of hepatitis B vaccination on hepatitis B disease and nucleic acid testing in high-prevalence populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Hepatitis B vaccine -- do we need boosters?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Recombinant DNA hepatitis B vaccination in teenagers: effect of a booster at 5 1/2 years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Short-term response to a booster dose of hepatitis B vaccine in anti-HBs negative adolescents who had received primary vaccination 16 years ago

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Hepatitis B revaccination in healthy non-responder Chinese children: five-year follow-up of immune response and immunologic memory.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.007

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.08.007

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45381982&oldid=2076273913"